{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T06:20:24Z","timestamp":1762410024812,"version":"build-2065373602"},"reference-count":68,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Neurology and Neurosurgery"],"published-print":{"date-parts":[[2022,2]]},"DOI":"10.1016\/j.clineuro.2022.107140","type":"journal-article","created":{"date-parts":[[2022,1,22]],"date-time":"2022-01-22T01:56:45Z","timestamp":1642816605000},"page":"107140","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"special_numbering":"C","title":["Characteristics, treatment, and outcomes of Myasthenia Gravis in COVID-19 patients: A systematic review"],"prefix":"10.1016","volume":"213","author":[{"given":"Alzhraa Salah","family":"Abbas","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicole","family":"Hardy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sherief","family":"Ghozy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mahmoud","family":"Dibas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Geeta","family":"Paranjape","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kirk W.","family":"Evanson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Natalie L.","family":"Reierson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kathryn","family":"Cowie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shelby","family":"Kamrowski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Scarlett","family":"Schmidt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yutao","family":"Tang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amber R.","family":"Davis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jillienne C.","family":"Touchette","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kevin M.","family":"Kallmes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ameer E.","family":"Hassan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ranita","family":"Tarchand","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mansi","family":"Mehta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John M.","family":"Pederson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohamed","family":"Abdelmegeed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.clineuro.2022.107140_bib1","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1007\/s00415-018-8751-9","article-title":"Myasthenia gravis and infectious disease","volume":"265","author":"Gilhus","year":"2018","journal-title":"J. Neurol."},{"key":"10.1016\/j.clineuro.2022.107140_bib2","article-title":"Guidance for the management of myasthenia gravis (MG) and Lambert-Eaton myasthenic syndrome (LEMS) during the COVID-19 pandemic","volume":"412","author":"International","year":"2020","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.clineuro.2022.107140_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.clineuro.2020.106045","article-title":"COVID-19 and generalized Myasthenia Gravis exacerbation: A case report","volume":"196","author":"Singh","year":"2020","journal-title":"Clin. Neurol. Neurosurg."},{"issue":"8","key":"10.1016\/j.clineuro.2022.107140_bib4","first-page":"308","article-title":"[Exacerbation of pseudoparalytic myasthenia gravis following azithromycin (Zithromax)]","volume":"126","author":"Cadisch","year":"1996","journal-title":"Schweiz Med Woche"},{"issue":"3","key":"10.1016\/j.clineuro.2022.107140_bib5","first-page":"849","article-title":"Myasthenia gravis due to hydroxychloroquine","volume":"67","author":"Varan","year":"2015","journal-title":"Reumatismo"},{"key":"10.1016\/j.clineuro.2022.107140_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.jns.2020.116888","article-title":"Myasthenic crisis in COVID-19","volume":"414","author":"Delly","year":"2020","journal-title":"J. Neurol. Sci."},{"issue":"6","key":"10.1016\/j.clineuro.2022.107140_bib7","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1001\/jamaneurol.2020.1127","article-title":"Neurologic Manifestations of Hospitalized Patients With Coronavirus Disease 2019 in Wuhan, China","volume":"77","author":"Mao","year":"2020","journal-title":"JAMA Neurol."},{"issue":"3","key":"10.1016\/j.clineuro.2022.107140_bib8","doi-asserted-by":"crossref","first-page":"361","DOI":"10.3233\/JND-200520","article-title":"COVID-19 in Refractory Myasthenia Gravis- A Case Report of Successful Outcome","volume":"7","author":"Ramaswamy","year":"2020","journal-title":"J. Neuromuscul. Dis."},{"issue":"5","key":"10.1016\/j.clineuro.2022.107140_bib9","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1007\/s00415-020-10149-2","article-title":"Management of patients with neuromuscular disorders at the time of the SARS-CoV-2 pandemic","volume":"268","author":"Costamagna","year":"2021","journal-title":"J. Neurol."},{"issue":"3","key":"10.1016\/j.clineuro.2022.107140_bib10","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1003583","article-title":"The PRISMA 2020 statement: An updated guideline for reporting systematic reviews","volume":"18","author":"Page","year":"2021","journal-title":"PLOS Med."},{"key":"10.1016\/j.clineuro.2022.107140_bib11","doi-asserted-by":"crossref","first-page":"b2700","DOI":"10.1136\/bmj.b2700","article-title":"The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration","volume":"339","author":"Liberati","year":"2009","journal-title":"BMJ"},{"issue":"1","key":"10.1016\/j.clineuro.2022.107140_bib12","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1212\/WNL.55.1.16","article-title":"Myasthenia gravis: recommendations for clinical research standards. Task Force of the Medical Scientific Advisory Board of the Myasthenia Gravis Foundation of America","volume":"55","author":"Jaretzki","year":"2000","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.clineuro.2022.107140_bib13","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1136\/ebmental-2019-300117","article-title":"How to perform a meta-analysis with R: a practical tutorial","volume":"22","author":"Balduzzi","year":"2019","journal-title":"Evid. -Based Ment. Health"},{"issue":"2","key":"10.1016\/j.clineuro.2022.107140_bib14","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1002\/mus.26918","article-title":"A.C. Guidon, COVID-19 in patients with myasthenia gravis","volume":"62","author":"Anand","year":"2020","journal-title":"Muscle Nerve"},{"issue":"10","key":"10.1016\/j.clineuro.2022.107140_bib15","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1136\/jnnp-2020-323565","article-title":"Management of patients with generalised myasthenia gravis and COVID-19: four case reports","volume":"91","author":"Hubers","year":"2020","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.clineuro.2022.107140_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.jns.2020.117053","article-title":"Description of 3 patients with myasthenia gravis and COVID-19","volume":"417","author":"Rein","year":"2020","journal-title":"J. Neurol. Sci."},{"issue":"4","key":"10.1016\/j.clineuro.2022.107140_bib17","doi-asserted-by":"crossref","first-page":"E65","DOI":"10.1002\/mus.27020","article-title":"COVID-19 in muscle-specific kinase myasthenia gravis: A case report","volume":"62","author":"Kushlaf","year":"2020","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.clineuro.2022.107140_bib18","article-title":"COVID-19 Presentation in Association with Myasthenia Gravis: A Case Report and Review of the Literature","volume":"2020","author":"Aksoy","year":"2020","journal-title":"Case Rep. Infect. Dis."},{"key":"10.1016\/j.clineuro.2022.107140_bib19","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.3389\/fneur.2020.01053","article-title":"Myasthenia Gravis and COVID-19: Clinical Characteristics and Outcomes","volume":"11","author":"Camelo-Filho","year":"2020","journal-title":"Front Neurol."},{"issue":"4","key":"10.1016\/j.clineuro.2022.107140_bib20","first-page":"524","article-title":"Isolated COVID-19 Infection Precipitates Myasthenia Gravis Crisis: A Case Report","volume":"4","author":"Moschella","year":"2020","journal-title":"Clin. Pr. Cases Emerg. Med"},{"issue":"8","key":"10.1016\/j.clineuro.2022.107140_bib21","doi-asserted-by":"crossref","first-page":"2700","DOI":"10.1007\/s00415-020-10310-x","article-title":"Myasthenic crisis following SARS-CoV-2 infection and delayed virus clearance in a patient treated with rituximab: clinical course and 6-month follow-up","volume":"268","author":"Wanschitz","year":"2021","journal-title":"J. Neurol."},{"issue":"9","key":"10.1016\/j.clineuro.2022.107140_bib22","doi-asserted-by":"crossref","first-page":"3125","DOI":"10.1007\/s00415-021-10428-6","article-title":"Complement inhibition initiated recovery of a severe myasthenic crisis with COVID-19","volume":"268","author":"Hofstadt-van Oy","year":"2021","journal-title":"J. Neurol."},{"key":"10.1016\/j.clineuro.2022.107140_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.ensci.2021.100332","article-title":"Case series: COVID-19 in patients with mild to moderate myasthenia gravis in a National Referral Hospital in Indonesia","volume":"23","author":"Octaviana","year":"2021","journal-title":"eNeurologicalSci"},{"issue":"4","key":"10.1016\/j.clineuro.2022.107140_bib24","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1007\/s13760-021-01662-w","article-title":"Case series of COVID-19 in patients with myasthenia gravis: a single institution experience","volume":"121","author":"Zupanic","year":"2021","journal-title":"Acta Neurol. Belg."},{"issue":"6","key":"10.1016\/j.clineuro.2022.107140_bib25","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1002\/phar.2524","article-title":"Use of Remdesivir in Myasthenia gravis and COVID-19","volume":"41","author":"Peters","year":"2021","journal-title":"Pharmacotherapy"},{"issue":"3","key":"10.1016\/j.clineuro.2022.107140_bib26","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1111\/ane.13440","article-title":"Myasthenia gravis and COVID-19: A case series and comparison with literature","volume":"144","author":"Saied","year":"2021","journal-title":"Acta Neurol. Scand."},{"issue":"2","key":"10.1016\/j.clineuro.2022.107140_bib27","doi-asserted-by":"crossref","first-page":"164","DOI":"10.5152\/eurasianjmed.2021.20364","article-title":"Favipiravir Experience in Covid-19 Positive Myasthenia Gravis Patients","volume":"53","author":"Yevgi","year":"2021","journal-title":"Eurasia J. Med"},{"issue":"2","key":"10.1016\/j.clineuro.2022.107140_bib28","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1002\/mus.27324","article-title":"COVID-19 in patients with myasthenia gravis: Epidemiology and disease course","volume":"64","author":"Businaro","year":"2021","journal-title":"Muscle Nerve"},{"issue":"10","key":"10.1016\/j.clineuro.2022.107140_bib29","doi-asserted-by":"crossref","first-page":"3418","DOI":"10.1111\/ene.14951","article-title":"Predictive factors for a severe course of COVID-19 infection in myasthenia gravis patients with an overall impact on myasthenic outcome status and survival","volume":"28","author":"Jakubikova","year":"2021","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.clineuro.2022.107140_bib30","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2020.576153","article-title":"Postinfectious Onset of Myasthenia Gravis in a COVID-19 Patient","volume":"11","author":"Huber","year":"2020","journal-title":"Front Neurol."},{"issue":"12","key":"10.1016\/j.clineuro.2022.107140_bib31","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1016\/S1474-4422(20)30413-0","article-title":"COVID-19-associated risks and effects in myasthenia gravis (CARE-MG)","volume":"19","author":"Muppidi","year":"2020","journal-title":"Lancet Neurol."},{"issue":"12","key":"10.1016\/j.clineuro.2022.107140_bib32","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.7326\/L20-0845","article-title":"Myasthenia Gravis Associated With SARS-CoV-2 Infection","volume":"173","author":"Restivo","year":"2020","journal-title":"Ann. Intern Med"},{"key":"10.1016\/j.clineuro.2022.107140_bib33","article-title":"New onset of ocular myasthenia gravis in a patient with COVID-19: a novel case report and literature review","author":"Sriwastava","year":"2020","journal-title":"J. Neurol."},{"issue":"6","key":"10.1016\/j.clineuro.2022.107140_bib34","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1212\/01.WNL.0000050461.05432.C5","article-title":"Myasthenia gravis: a higher than expected incidence in the elderly","volume":"60","author":"Aragones","year":"2003","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.clineuro.2022.107140_bib35","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1111\/jgs.12629","article-title":"Myasthenia gravis: a disease of the very old","volume":"62","author":"Aragones","year":"2014","journal-title":"J. Am. Geriatr. Soc."},{"key":"10.1016\/j.clineuro.2022.107140_bib36","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/1471-2377-10-46","article-title":"A systematic review of population based epidemiological studies in Myasthenia Gravis","volume":"10","author":"Carr","year":"2010","journal-title":"BMC Neurol."},{"issue":"8","key":"10.1016\/j.clineuro.2022.107140_bib37","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1136\/jnnp.74.8.1105","article-title":"Evidence of underdiagnosis of myasthenia gravis in older people","volume":"74","author":"Vincent","year":"2003","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"3","key":"10.1016\/j.clineuro.2022.107140_bib38","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1111\/cei.12217","article-title":"Myasthenia gravis: an update for the clinician","volume":"175","author":"Sieb","year":"2014","journal-title":"Clin. Exp. Immunol."},{"issue":"2","key":"10.1016\/j.clineuro.2022.107140_bib39","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1212\/CPJ.0b013e31828d9fec","article-title":"Myasthenia gravis: Five new things","volume":"3","author":"Statland","year":"2013","journal-title":"Neurol. Clin. Pr."},{"issue":"11","key":"10.1016\/j.clineuro.2022.107140_bib40","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1001\/jama.2020.1585","article-title":"Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China","volume":"323","author":"Wang","year":"2020","journal-title":"JAMA"},{"issue":"4","key":"10.1016\/j.clineuro.2022.107140_bib41","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.21037\/apm-20-887","article-title":"Provincial Medical Treatment Expert Group of, Clinical characteristics of coronavirus disease 2019 in Gansu province, China, Ann","volume":"9","author":"Yue","year":"2020","journal-title":"Palliat. Med"},{"issue":"Suppl 6","key":"10.1016\/j.clineuro.2022.107140_bib42","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1186\/1471-2105-15-S6-S3","article-title":"Data-driven discovery of seasonally linked diseases from an Electronic Health Records system","volume":"15","author":"Melamed","year":"2014","journal-title":"BMC Bioinforma."},{"issue":"7","key":"10.1016\/j.clineuro.2022.107140_bib43","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1111\/ene.12703","article-title":"Myasthenia gravis: descriptive analysis of life-threatening events in a recent nationwide registry","volume":"22","author":"Ramos-Fransi","year":"2015","journal-title":"Eur. J. Neurol."},{"issue":"2","key":"10.1016\/j.clineuro.2022.107140_bib44","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1046\/j.1468-1331.1998.520137.x","article-title":"The management and outcome of patients with myasthenia gravis treated acutely in a neurological intensive care unit","volume":"5","author":"O\u2019Riordan","year":"1998","journal-title":"Eur. J. Neurol."},{"issue":"5","key":"10.1016\/j.clineuro.2022.107140_bib45","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1212\/WNL.48.5.1253","article-title":"Myasthenic crisis: clinical features, mortality, complications, and risk factors for prolonged intubation","volume":"48","author":"Thomas","year":"1997","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.clineuro.2022.107140_bib46","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1177\/1941875210382918","article-title":"Myasthenic crisis","volume":"1","author":"Wendell","year":"2011","journal-title":"Neurohospitalist"},{"issue":"6","key":"10.1016\/j.clineuro.2022.107140_bib47","doi-asserted-by":"crossref","first-page":"872","DOI":"10.7326\/L20-1298","article-title":"MuSK Antibody-Associated Myasthenia Gravis With SARS-CoV-2 Infection: A Case Report","volume":"174","author":"Muhammed","year":"2021","journal-title":"Ann. Intern Med"},{"issue":"10","key":"10.1016\/j.clineuro.2022.107140_bib48","doi-asserted-by":"crossref","first-page":"3537","DOI":"10.1111\/ene.14721","article-title":"Myasthenia gravis associated with anti-MuSK antibodies developed after SARS-CoV-2 infection","volume":"28","author":"Assini","year":"2021","journal-title":"Eur. J. Neurol."},{"issue":"26","key":"10.1016\/j.clineuro.2022.107140_bib49","doi-asserted-by":"crossref","first-page":"2570","DOI":"10.1056\/NEJMra1602678","volume":"375","author":"Gilhus","year":"2016","journal-title":"N. Engl. J. Med"},{"issue":"9","key":"10.1016\/j.clineuro.2022.107140_bib50","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/j.autrev.2013.03.007","article-title":"The different roles of the thymus in the pathogenesis of the various myasthenia gravis subtypes","volume":"12","author":"Marx","year":"2013","journal-title":"Autoimmun. Rev."},{"issue":"1\u20132","key":"10.1016\/j.clineuro.2022.107140_bib51","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/S0165-5728(02)00145-5","article-title":"Titin and ryanodine receptor epitopes are expressed in cortical thymoma along with costimulatory molecules","volume":"128","author":"Romi","year":"2002","journal-title":"J. Neuroimmunol."},{"issue":"6","key":"10.1016\/j.clineuro.2022.107140_bib52","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1056\/NEJMoa1602489","article-title":"Randomized Trial of Thymectomy in Myasthenia Gravis","volume":"375","author":"Wolfe","year":"2016","journal-title":"N. Engl. J. Med"},{"issue":"6","key":"10.1016\/j.clineuro.2022.107140_bib53","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1136\/ard.2010.144741","article-title":"The influence of systemic glucocorticoid therapy upon the risk of non-serious infection in older patients with rheumatoid arthritis: a nested case-control study","volume":"70","author":"Dixon","year":"2011","journal-title":"Ann. Rheum. Dis."},{"issue":"5","key":"10.1016\/j.clineuro.2022.107140_bib54","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1002024","article-title":"Common Infections in Patients Prescribed Systemic Glucocorticoids in Primary Care: A Population-Based Cohort Study","volume":"13","author":"Fardet","year":"2016","journal-title":"PLoS Med"},{"issue":"5","key":"10.1016\/j.clineuro.2022.107140_bib55","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1002025","article-title":"Steroid-Based Therapy and Risk of Infectious Complications","volume":"13","author":"Rostaing","year":"2016","journal-title":"PLoS Med"},{"issue":"10235","key":"10.1016\/j.clineuro.2022.107140_bib56","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1016\/S0140-6736(20)30920-X","article-title":"SARS-CoV-2 and viral sepsis: observations and hypotheses","volume":"395","author":"Li","year":"2020","journal-title":"Lancet"},{"issue":"10229","key":"10.1016\/j.clineuro.2022.107140_bib57","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/S0140-6736(20)30628-0","article-title":"Across Speciality Collaboration, COVID-19: consider cytokine storm syndromes and immunosuppression","volume":"395","author":"Mehta","year":"2020","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.clineuro.2022.107140_bib58","doi-asserted-by":"crossref","first-page":"13497","DOI":"10.1038\/s41598-020-70539-4","article-title":"Intravenous immunoglobulins may prevent prednisone-exacerbation in myasthenia gravis","volume":"10","author":"Diez-Porras","year":"2020","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.clineuro.2022.107140_bib59","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1186\/s13054-020-2836-4","article-title":"A novel treatment approach to the novel coronavirus: an argument for the use of therapeutic plasma exchange for fulminant COVID-19","volume":"24","author":"Keith","year":"2020","journal-title":"Crit. Care"},{"key":"10.1016\/j.clineuro.2022.107140_bib60","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.3389\/fimmu.2020.01660","article-title":"High-Dose Intravenous Immunoglobulins in the Treatment of Severe Acute Viral Pneumonia: The Known Mechanisms and Clinical Effects","volume":"11","author":"Liu","year":"2020","journal-title":"Front Immunol."},{"issue":"7","key":"10.1016\/j.clineuro.2022.107140_bib61","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2020.102554","article-title":"Convalescent plasma in Covid-19: Possible mechanisms of action","volume":"19","author":"Rojas","year":"2020","journal-title":"Autoimmun. Rev."},{"issue":"4","key":"10.1016\/j.clineuro.2022.107140_bib62","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1001\/archneur.1989.00520400124033","article-title":"Myasthenic syndrome caused by direct effect of chloroquine on neuromuscular junction","volume":"46","author":"Robberecht","year":"1989","journal-title":"Arch. Neurol."},{"issue":"24","key":"10.1016\/j.clineuro.2022.107140_bib63","doi-asserted-by":"crossref","first-page":"2372","DOI":"10.1056\/NEJMc2010419","article-title":"Clinical Characteristics of Covid-19 in New York City","volume":"382","author":"Goyal","year":"2020","journal-title":"N. Engl. J. Med"},{"issue":"4","key":"10.1016\/j.clineuro.2022.107140_bib64","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1016\/j.injury.2020.02.098","article-title":"Hemiarthroplasty compared with internal fixation for treatment of nondisplaced femoral neck fractures in elderly patients: a retrospective study","volume":"51","author":"Chen","year":"2020","journal-title":"Injury"},{"issue":"20","key":"10.1016\/j.clineuro.2022.107140_bib65","doi-asserted-by":"crossref","first-page":"2052","DOI":"10.1001\/jama.2020.6775","article-title":"Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area","volume":"323","author":"Richardson","year":"2020","journal-title":"JAMA"},{"issue":"10229","key":"10.1016\/j.clineuro.2022.107140_bib66","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/S0140-6736(20)30566-3","article-title":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study","volume":"395","author":"Zhou","year":"2020","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.clineuro.2022.107140_bib67","first-page":"377","article-title":"Hospital length of stay among COVID-19-positive patients","volume":"7","author":"Chiam","year":"2021","journal-title":"J. Clin. Transl. Res"},{"issue":"1","key":"10.1016\/j.clineuro.2022.107140_bib68","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1186\/s12916-020-01726-3","article-title":"COVID-19 length of hospital stay: a systematic review and data synthesis","volume":"18","author":"Rees","year":"2020","journal-title":"BMC Med"}],"container-title":["Clinical Neurology and Neurosurgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S030384672200021X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S030384672200021X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T14:39:58Z","timestamp":1759588798000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S030384672200021X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2]]},"references-count":68,"alternative-id":["S030384672200021X"],"URL":"https:\/\/doi.org\/10.1016\/j.clineuro.2022.107140","relation":{},"ISSN":["0303-8467"],"issn-type":[{"type":"print","value":"0303-8467"}],"subject":[],"published":{"date-parts":[[2022,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Characteristics, treatment, and outcomes of Myasthenia Gravis in COVID-19 patients: A systematic review","name":"articletitle","label":"Article Title"},{"value":"Clinical Neurology and Neurosurgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clineuro.2022.107140","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"107140"}}